LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

Search

PerkinElmer Inc

Closed

SectorHealthcare

0

Overview

Share price change

24h

Current

Min

Max

Key metrics

By Trading Economics

Income

-52M

42M

Sales

-65M

665M

P/E

Sector Avg

38.967

54.533

EPS

1.01

Dividend yield

0.3

Profit margin

6.354

Employees

11,000

EBITDA

-151M

72M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+30.5% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.30%

2.41%

Next Earnings

28 lip 2025

Next Dividend date

8 sie 2025

Next Ex Dividend date

18 lip 2025

Market Stats

By TradingEconomics

Market Cap

-2.9B

11B

Previous open

0

Previous close

0

News Sentiment

By Acuity

39%

61%

130 / 382 Ranking in Healthcare

PerkinElmer Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

23 maj 2025, 20:33 UTC

Acquisitions, Mergers, Takeovers

Salesforce in Talks to Buy Informatica, Bloomberg Reports, Citing Sources

23 maj 2025, 21:57 UTC

Hot Stocks

Stocks to Watch: Apple, Booz Allen, Constellation Energy, Intuit -- WSJ

23 maj 2025, 21:15 UTC

Top News

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- 4th Update

23 maj 2025, 21:04 UTC

Acquisitions, Mergers, Takeovers

Real-Estate Broker Douglas Elliman Could See Takeover Battle After Report of Bid -- Barrons.com

23 maj 2025, 20:56 UTC

Top News
Acquisitions, Mergers, Takeovers

Salesforce Back in Deal Talks With Informatica -- WSJ

23 maj 2025, 20:51 UTC

Top News

Boeing in Tentative Agreement to Pay $1.1 Billion to Avoid Trial for 737 MAX Crashes -- WSJ

23 maj 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

23 maj 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

23 maj 2025, 20:41 UTC

Top News

Stocks Fall on Tariff Broadside, After Week of Bond Market Agita -- WSJ

23 maj 2025, 20:28 UTC

Top News

Trump Threatens EU With 50% Tariffs, Takes Aim at Apple; Nasdaq Drops -- WSJ

23 maj 2025, 20:06 UTC

Top News

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- 5th Update

23 maj 2025, 20:06 UTC

Acquisitions, Mergers, Takeovers

Salesforce Stock Drops, Informatica Soars. A Deal May Be Back on the Table. -- Barrons.com

23 maj 2025, 19:50 UTC

Top News

Trump's Tariffs: Where Things Stand -- 16th Update

23 maj 2025, 19:28 UTC

Acquisitions, Mergers, Takeovers

Trump on Truth Social: 'Bulk of That Investment Will Occur in the Next 14 Months'

23 maj 2025, 19:28 UTC

Acquisitions, Mergers, Takeovers

Trump on Truth Social: 'This Will Be a Planned Partnership Between United States Steel and Nippon Steel'

23 maj 2025, 19:27 UTC

Acquisitions, Mergers, Takeovers

Trump on Truth Social: 'Proud to Announce That, After Much Consideration and Negotiation, US Steel Will REMAIN in America'

23 maj 2025, 19:20 UTC

Market Talk

Crude Futures Post Modest Weekly Losses -- Market Talk

23 maj 2025, 19:18 UTC

Market Talk

U.S. Natural Gas Futures End Week Unchanged -- Market Talk

23 maj 2025, 18:57 UTC

Top News

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- 4th Update

23 maj 2025, 18:54 UTC

Top News

Trump Threatens Fresh Tariffs on EU, iPhones and Rival Devices -- Update

23 maj 2025, 18:53 UTC

Top News
Acquisitions, Mergers, Takeovers

McDonald's Bids Goodbye to CosMc's, Its Space Alien-Themed Spinoff -- WSJ

23 maj 2025, 18:52 UTC

Acquisitions, Mergers, Takeovers

DDC Enterprise Issues 254,333 Class A Ordinary Shrs in Exchange for 21 BTC, Valued at About $2.28M in Current Market Price

23 maj 2025, 18:13 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

23 maj 2025, 18:13 UTC

Market Talk

Gold Trades Higher on Reminder of Risk -- Market Talk

23 maj 2025, 18:00 UTC

Top News

Apple's Stock Still Not Pricing in Trump's Demands - Heard on the Street -- WSJ

23 maj 2025, 17:51 UTC

Market Talk
Earnings

Workday Sees Higher Bar for Guidance -- Market Talk

23 maj 2025, 17:42 UTC

Top News

Dow Drops, Trump Threatens EU With 50% Tariffs, Takes Aim at Apple -- WSJ

23 maj 2025, 17:39 UTC

Market Talk

U.S. Oil Rig Count Falls to Lowest Level Since November 2021 -- Market Talk

23 maj 2025, 17:07 UTC

Top News

Trump's Tariffs: Where Things Stand -- 15th Update

23 maj 2025, 17:04 UTC

Market Talk
Earnings

Workday Appears to Have Upside Potential on Conservative Outlook -- Market Talk

Peer Comparison

Price change

PerkinElmer Inc Forecast

Price Target

By TipRanks

30.5% upside

12 Months Forecast

Average 118.08 USD  30.5%

High 135 USD

Low 100 USD

Based on 14 Wall Street analysts offering 12 month price targets forPerkinElmer Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

14 ratings

9

Buy

5

Hold

0

Sell

Sentiment

By Acuity

130 / 382 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About PerkinElmer Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.